We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Heranba Industries Limited manufactures, markets, and sells a range of agrochemicals in India. The company provides intermediates, such as cypermethric acid chloride, high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and technical products, including cypermethrin, deltamethrin, alpha cypermethrin, acephate, lambda cyhalothrin, bifenthrin, and tranfluthrin, as well as tricyclazole, hexaconazole, tebuconazole, glyphosate, metribuzin, clodinafop, and bispyribac sodium. It also offers formulations comprising emulsifiable concentrate, water dispersible granule, suspension concentrate, capsule suspension, oil dispersion, concentrated aqueous emulsions, suspoemulsion, and zc formulation. In addition, the company provides various pesticides, including insecticides, herbicides, fungicides, and public health products for pest control. Heranba Industries Limited also exports its products to approximately 65 countries. The company was formerly known as Heranba Industrial Chemicals Limited and changed its name to Heranba Industries Limited in July 1996. Heranba Industries Limited was incorporated in 1992 and is based in Mumbai, India.
TODAY'S HIGH
583.9
TODAY'S LOW
560
52 WEEK HIGH
835.6
52 WEEK LOW
480
% of Shares Held by
All Insider
75.89%
% of Shares Held by
Institutions
2.96%
% of Float Held by
Institutions
12.30%
Number of Institutions
Holding Shares
4
MARKET CAP
2249.95 Cr.
ETERPRISE VALUE
2222.03 Cr.
NO. OF SHARES
4 Cr.
BOOK VALUE
178.554
DIV. YIELD
2%
DEBT
61.04 Cr.
GROSS PROFIT
514.07 Cr.
CASH
105.37 Cr.
REVENUE
1460.90 Cr.
REVENUE/SHARE
365.194
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Investments | -3.08 Cr. | -18.28 Cr. | -3.76 Cr. | -56.30 Lakhs |
Change To Liabilities | 46.86 Cr. | -16.42 Cr. | -24.56 Cr. | 59.09 Cr. |
Total cashflows from Investing Activities | -81.67 Cr. | -40.71 Cr. | -52.03 Cr. | -37.37 Cr. |
Net Borrowings | 2.20 Lakhs | 6.63 Cr. | -6.85 Cr. | -26.11 Cr. |
Total Cash from Financing Activities | -6.28 Cr. | 61.90 Cr. | -19.94 Cr. | -41.13 Cr. |
Other Liabilities | 2.80 Cr. | 5.53 Cr. | 8.92 Cr. | 8.92 Cr. |
Total Assets | 0 | 625.23 Cr. | 625.23 Cr. | 625.23 Cr. |
Net Income | 189.06 Cr. | 154.22 Cr. | 97.65 Cr. | 75.40 Cr. |
Change in Cash | 10.21 Cr. | 81.58 Cr. | -17.77 Cr. | 9.18 Cr. |
Effect of Exchange Rate | 0 | 0 | 0 | 0 |
Total Cash from Operating Activities | 98.17 Cr. | 60.39 Cr. | 54.20 Cr. | 87.70 Cr. |
Depreciation | 19.78 Cr. | 14.68 Cr. | 8.20 Cr. | 5.95 Cr. |
Other Cashflows from Investing Activities | 1.92 Cr. | 71.80 Lakhs | 51.30 Lakhs | 95.60 Lakhs |
Dividends Paid | -2.80 Cr. | -5.85 Cr. | -3.90 Cr. | -3.90 Cr. |
Change to Inventory | -89.75 Cr. | -20.46 Cr. | -31.62 Cr. | -19.89 Cr. |
Change to Account Receivables | -70.59 Cr. | -89.83 Cr. | 2.43 Cr. | -40.95 Cr. |
Other Cashflows from Financing Activities | -3.50 Cr. | -564.11 Cr. | -9.18 Cr. | -11.11 Cr. |
Change to Net Income | 1.30 Lakhs | 12.67 Cr. | -6.81 Cr. | 8.10 Cr. |
Capital Expenditures | -80.53 Cr. | -24.10 Cr. | -47.92 Cr. | -37.77 Cr. |
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Research Development | None | None | None | None |
Effect of Accounting Charges | None | None | None | None |
Income Before Tax | 255.25 Cr. | 208.28 Cr. | 128.84 Cr. | 122.12 Cr. |
Minority Interest | None | None | None | None |
Net Income | 239.97 Cr. | 206.65 Cr. | 121.14 Cr. | 125.46 Cr. |
Selling General Administrative | 58.44 Cr. | 52.18 Cr. | 46.46 Cr. | 38 Cr. |
Gross Profit | 519.76 Cr. | 434.71 Cr. | 309.84 Cr. | 300.19 Cr. |
Ebit | 239.97 Cr. | 206.65 Cr. | 121.14 Cr. | 125.46 Cr. |
Operating Income | 239.97 Cr. | 206.65 Cr. | 121.14 Cr. | 125.46 Cr. |
Other Operating Expenses | 201.56 Cr. | 161.19 Cr. | 134.03 Cr. | 130.77 Cr. |
Interest Expense | -4.07 Cr. | -5.39 Cr. | -8.83 Cr. | -10.73 Cr. |
Extraordinary Items | None | None | None | None |
Non Recurring | None | None | None | None |
Other Items | None | None | None | None |
Income Tax Expense | 66.18 Cr. | 54.05 Cr. | 31.18 Cr. | 46.71 Cr. |
Total Revenue | 1450.37 Cr. | 1218.64 Cr. | 951.37 Cr. | 1004.44 Cr. |
Total Operating Expenses | 1210.39 Cr. | 1011.99 Cr. | 830.22 Cr. | 878.98 Cr. |
Cost of Revenue | 930.60 Cr. | 783.92 Cr. | 641.52 Cr. | 704.25 Cr. |
Total Other Income Expense Net | 15.27 Cr. | 1.63 Cr. | 7.69 Cr. | -3.34 Cr. |
Discontinued Operations | None | None | None | None |
Net Income from Continuous Ops. | 189.06 Cr. | 154.22 Cr. | 97.65 Cr. | 75.40 Cr. |
Net Income Applicable to Common Shares | 189.06 Cr. | 154.22 Cr. | 97.65 Cr. | 75.40 Cr. |
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Intangible Assets | 0 | 0 | 0 | 0 |
Capital Surplus | 0 | 58.17 Cr. | 42.20 Lakhs | 42.20 Lakhs |
Total Liabilities | 354.17 Cr. | 315.17 Cr. | 303.91 Cr. | 332.26 Cr. |
Stock Holder Equity | 714.45 Cr. | 528.13 Cr. | 320.84 Cr. | 228.17 Cr. |
Minority Interest | 0 | 0 | 0 | 0 |
Other Liabilities | 40.63 Cr. | 41.37 Cr. | 24.30 Cr. | 24.22 Cr. |
Total Assets | 1068.63 Cr. | 843.31 Cr. | 624.76 Cr. | 560.44 Cr. |
Common Stock | 40.01 Cr. | 40.01 Cr. | 39.05 Cr. | 39.05 Cr. |
Retained Earnings | 0 | 429.39 Cr. | 280.91 Cr. | 188.44 Cr. |
Other Liabilities | 14.94 Cr. | 8.88 Cr. | 8.40 Cr. | 10.27 Cr. |
Good Will | 0 | 0 | 0 | 0 |
Treasury Stock | 674.44 Cr. | 54.40 Lakhs | 45.90 Lakhs | 25.10 Lakhs |
Other Assets | 20.16 Cr. | 17.53 Cr. | 11.80 Cr. | 37.28 Cr. |
Cash | 119.87 Cr. | 84.78 Cr. | 3.19 Cr. | 20.96 Cr. |
Current Liabilities | 338.59 Cr. | 305.12 Cr. | 295.28 Cr. | 321.99 Cr. |
Long Term Asset Charges | 2.80 Cr. | 1.02 Cr. | 0 | 0 |
Short Long Term Debt | 0 | 0 | 0 | 50 k |
Other Stockholder Equity | 674.44 Cr. | 54.40 Lakhs | 45.90 Lakhs | 25.10 Lakhs |
Property Plant Equipment | 207.65 Cr. | 143.13 Cr. | 133.21 Cr. | 67.10 Cr. |
Total Cur. Assets | 838.68 Cr. | 655.19 Cr. | 471.32 Cr. | 451.60 Cr. |
Long Term Investments | 2.12 Cr. | 27.45 Cr. | 8.42 Cr. | 4.44 Cr. |
Net Tangible Assets | 714.45 Cr. | 528.13 Cr. | 320.84 Cr. | 228.17 Cr. |
Short Term Investments | 0 | 0 | 0 | 0 |
Net Receivables | 409.64 Cr. | 341.92 Cr. | 259.52 Cr. | 253.39 Cr. |
Long Term Debt | 0 | 0 | 0 | 0 |
Inventory | 255.73 Cr. | 165.98 Cr. | 145.51 Cr. | 113.89 Cr. |
Accounts Payable | 243.23 Cr. | 195.58 Cr. | 212.46 Cr. | 235.20 Cr. |